Bigger India
Eight Chinese pharma cos to be blacklisted for quality issues, may lead to shortage of medicines
The notices were issued after a special inspection team of the Drug Controller General of India (DCGI) inspected the eight companies in China.
The Indian government has issued show cause notices to, and may soon blacklist, eight Chinese pharmaceutical companies found to be supplying poor quality raw material to drug manufacturers in this country.
Representational image. AFPRepresentational image. AFP
The notices were issued after a special inspection team of the Drug Controller General of India (DCGI) inspected the eight companies in China.
According to documents available with IANS, the eight companies are M/S Qilu Tianhe Pharmaceuticals, M/S Hinan Xinxiang Pharmaceuticals, M/S Zhuhai United Laboratories, M/S Guangzhao Baiyunshan Pharmaceuticals, M/S Shouguang Fukang Pharmaceuticals, M/S Qilu Antibiotics (Linyi) Pharmaceuticals, M/S Qindao Brightmoon Seawoods and M/S Shanghaoi Xiandia Hasen (Shangqiu) Pharmaceuticals.